Liberia vs Sao Tome and Principe: Protecting minority investors: Strength of minority investor
Protecting minority investors: Strength of minority investor over time
- Liberia
- Sao Tome and Principe
How they compare
Liberia currently reports 11 DB15-20 methodology against 10 DB15-20 methodology in Sao Tome and Principe, a difference of 1 DB15-20 methodology.
That makes Liberia's figure about 1.1 times Sao Tome and Principe's.
Across all 7 years both countries report, Liberia has been ahead every year.
Liberia ranks 177th and Sao Tome and Principe ranks 180th of 191 countries.
Liberia has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, Liberia or Sao Tome and Principe?
- Liberia, at 11 DB15-20 methodology against 10 DB15-20 methodology in Sao Tome and Principe as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between Liberia and Sao Tome and Principe?
- 1 DB15-20 methodology, with Liberia ahead.
- How many years of comparable data are there for Liberia and Sao Tome and Principe?
- 7 years are reported by both, from 2013 to 2019.
- How do Liberia and Sao Tome and Principe rank globally for protecting minority investors: strength of minority investor?
- Liberia ranks 177th and Sao Tome and Principe ranks 180th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.